Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-09

Clinical Trial Update: RETeval Study for Diabetic Retinopathy [NA]

View source ↗

Summary

The RETeval study for diabetic retinopathy has completed and results were posted in May 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RETEval

Snippet

Sponsor: Inoveon Corporation | Conditions: Diabetic Retinopathy | NA | Status: COMPLETED | Results posted: 2017-05-09